CLEVELAND & SAN FRANCISCO--(BUSINESS WIRE)--Ogenix Corporation today announced that it has agreed to grant an option to license its Transdermal Sustained Oxygen Therapy (TSOT) technology for wound healing and the treatment of skin disorders to Minerva Healthcare, Inc., for worldwide (except in Canada) distribution of its EpiFLO SD® family of products.
